164 related articles for article (PubMed ID: 11900766)
21. Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.
Sadzot B; Baraban JM; Glennon RA; Lyon RA; Leonhardt S; Jan CR; Titeler M
Psychopharmacology (Berl); 1989; 98(4):495-9. PubMed ID: 2505289
[TBL] [Abstract][Full Text] [Related]
22. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.
Winter JC; Helsley S; Fiorella D; Rabin RA
Pharmacol Biochem Behav; 1999 Jul; 63(3):507-13. PubMed ID: 10418794
[TBL] [Abstract][Full Text] [Related]
23. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Rickli A; Moning OD; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
[TBL] [Abstract][Full Text] [Related]
24. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.
Helsley S; Fiorella D; Rabin RA; Winter JC
Pharmacol Biochem Behav; 1998 Feb; 59(2):419-25. PubMed ID: 9476990
[TBL] [Abstract][Full Text] [Related]
25. Role of serotonergic 5-HT2A receptors in the psychotomimetic actions of phencyclidine.
Rabin RA; Doat M; Winter JC
Int J Neuropsychopharmacol; 2000 Dec; 3(4):333-338. PubMed ID: 11343613
[TBL] [Abstract][Full Text] [Related]
26. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
27. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
[TBL] [Abstract][Full Text] [Related]
28. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
[TBL] [Abstract][Full Text] [Related]
29. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
Winter JC; Filipink RA; Timineri D; Helsley SE; Rabin RA
Pharmacol Biochem Behav; 2000 Jan; 65(1):75-82. PubMed ID: 10638639
[TBL] [Abstract][Full Text] [Related]
30. Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.
Eshleman AJ; Forster MJ; Wolfrum KM; Johnson RA; Janowsky A; Gatch MB
Psychopharmacology (Berl); 2014 Mar; 231(5):875-88. PubMed ID: 24142203
[TBL] [Abstract][Full Text] [Related]
31. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
[TBL] [Abstract][Full Text] [Related]
32. Discriminative stimulus effects of N,N-diisopropyltryptamine.
Carbonaro TM; Forster MJ; Gatch MB
Psychopharmacology (Berl); 2013 Mar; 226(2):241-6. PubMed ID: 23070023
[TBL] [Abstract][Full Text] [Related]
33. Hallucinogens and Serotonin 5-HT
López-Giménez JF; González-Maeso J
Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
[TBL] [Abstract][Full Text] [Related]
34. Abuse liability profile of three substituted tryptamines.
Gatch MB; Forster MJ; Janowsky A; Eshleman AJ
J Pharmacol Exp Ther; 2011 Jul; 338(1):280-9. PubMed ID: 21474568
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD
Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278
[TBL] [Abstract][Full Text] [Related]
36. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
Fantegrossi WE; Harrington AW; Kiessel CL; Eckler JR; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Pharmacol Biochem Behav; 2006 Jan; 83(1):122-9. PubMed ID: 16460788
[TBL] [Abstract][Full Text] [Related]
37. Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
Egan CT; Herrick-Davis K; Miller K; Glennon RA; Teitler M
Psychopharmacology (Berl); 1998 Apr; 136(4):409-14. PubMed ID: 9600588
[TBL] [Abstract][Full Text] [Related]
38. Substituted hexahydrobenzodipyrans as 5-HT2A/2C receptor probes.
Whiteside MS; Kurrasch-Orbaugh D; Marona-Lewicka D; Nichols DE; Monte A
Bioorg Med Chem; 2002 Oct; 10(10):3301-6. PubMed ID: 12150876
[TBL] [Abstract][Full Text] [Related]
39. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
[TBL] [Abstract][Full Text] [Related]
40. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
Koerner J; Appel JB
Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
